Identification of Iatrogenic Drug Events Upon Admission to the Adult Emergency Departments

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT07333131

Acronym

IATRO-URG

Enrollment

100

Registered

2026-01-12

Start date

2025-07-09

Completion date

2026-05-09

Last updated

2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Iatrogenic Drug Events

Keywords

Iatrogenic drug events, Pharmaceutical intervention, Medication-related iatrogenesis

Brief summary

Pharmacists working within a multidisciplinary team have a role to play in detecting the potential iatrogenic origin of a hospital admission, in order to implement measures to improve medication use appropriately and limit readmissions for medication-related iatrogenesis. The iatrogenic detection process depends on the individual involved, their experience, and any tools consulted. Indeed, detection aids have their place in this process and aim for better identification. For example, a questionnaire called AT HARM 10 was developed by a team of experienced pharmacists to identify hospitalizations related to medication-related iatrogenesis. The use of this tool has been validated for pharmacists as well as for pharmacy students: interns and fifth-year medical students. Identifying iatrogenic drug events among patients presenting to the emergency department using the AT HARM 10 grid in order to intervene and adapt therapeutic management. This clinical pharmacy activity complements what is already included in routine care (medication review, pharmaceutical analysis, and pharmaceutical intervention to adapt treatment).

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

66 Years to No maximum

Healthy volunteers

Inclusion criteria

* Adult patient (\> 65 years old) * Treated in the emergency department of Hautepierre Hospital * Presenting a prioritization score \> 7 according to the Von Korff score * Subject (and their legal representative, if applicable) not objecting to the reuse of their data for scientific research purposes.

Exclusion criteria

\- Presence of a written objection in the patient's medical file (and/or that of their legal representative, if applicable) to the reuse of their data for scientific research purposes

Design outcomes

Primary

Measure	Time frame
Number of patients for whom an iatrogenic event was identified	Up to 9 months

Countries

France

Contacts

Primary ContactJulia WALTHER, PharmD

julia.walther@chru-strasbourg.fr33 3 88 12 78 18

Outcome results